Pharmacodynamic effects of seliciclib, an orally administered cell cycle modulator, in undifferentiated nasopharyngeal cancer

• Main Authors: Hsieh, W.-S., Soo, R., Pen, B.-K., Loh, T., Dong, D., Son, D., Wong, L.-S., Green, S., Chiao, J., Cui, C.-Y., Lai, Y.-F., Lee, S.-C., Mow, B., Soong, R., Salto-Tellez, M., Goh, B.-C.
• 其他作者: CANCER SCIENCE INSTITUTE OF SINGAPORE
• 格式: Article
• 出版: 2014
• 在線閱讀: http://scholarbank.nus.edu.sg/handle/10635/115864

10.1158/1078-0432.CCR-08-1748